vorinostat has been researched along with B16 Melanoma in 4 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Excerpt | Relevance | Reference |
---|---|---|
"To improve the bioavailability and anticancer potential of suberoylanilide hydroxamic acid (SAHA) by developing a drug-loaded polymeric nanomicellar system." | 1.46 | Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo. ( Biswas, S; Ghanta, P; Ghosh, B; Kiran Rompicharla, SV; Kumari, P; Trivedi, P, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Wu, R | 1 |
Wang, C | 2 |
Li, Z | 2 |
Xiao, J | 1 |
Li, C | 1 |
Wang, X | 1 |
Kong, P | 1 |
Cao, J | 1 |
Huang, F | 1 |
Huang, Y | 1 |
Chen, Y | 1 |
Li, X | 1 |
Yang, D | 1 |
Zhang, H | 1 |
Mai, J | 1 |
Feng, G | 1 |
Deng, R | 1 |
Zhu, X | 1 |
Lu, F | 1 |
Hou, L | 1 |
Wang, S | 1 |
Yu, Y | 1 |
Zhang, Y | 1 |
Sun, L | 1 |
Ma, Z | 1 |
Yang, F | 1 |
Sagwal, SK | 1 |
Pasqual-Melo, G | 1 |
Bodnar, Y | 1 |
Gandhirajan, RK | 1 |
Bekeschus, S | 1 |
Kiran Rompicharla, SV | 1 |
Trivedi, P | 1 |
Kumari, P | 1 |
Ghanta, P | 1 |
Ghosh, B | 1 |
Biswas, S | 1 |
4 other studies available for vorinostat and B16 Melanoma
Article | Year |
---|---|
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
Topics: Animals; Antineoplastic Agents; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Drug Resistance, Neoplasm | 2020 |
Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Survival; Chemistry, Pharmac | 2021 |
Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16.
Topics: Animals; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Death; Cell Line, Tumor | 2018 |
Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Chromatography, High Pres | 2017 |